HELP     Sign In
Search

Relevance to Autism

Two de novo missense variants in the TET2 gene have been identified in ASD probands from the Simons Simplex Collection, with no de novo events in this gene observed in 1,786 unaffected siblings (P=0.02) (Iossifov et al., 2014; Krumm et al., 2015).

Molecular Function

The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. In addition to its role in DNA demethylation, TET2 isalso involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
The contribution of de novo coding mutations to autism spectrum disorder
ASD
Support
Genome-wide characteristics of de novo mutations in autism
ASD
Support
Excess of rare, inherited truncating mutations in autism.
ASD
Support
Whole genome sequencing analysis identifies sex differences of familial pattern contributing to phenotypic diversity in autism
ASD
Support
ASD
Support
Integrating de novo and inherited variants in 42
ASD
Support
2022
TS
Support
Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder.
ASD
Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN728R001 
 missense_variant 
 c.5008C>T 
 p.Leu1670Phe 
 De novo 
  
 Simplex 
 GEN728R002 
 missense_variant 
 c.789G>T 
 p.Glu263Asp 
 De novo 
  
 Simplex 
 GEN728R003 
 missense_variant 
 c.2392G>A 
 p.Glu798Lys 
 De novo 
  
 Simplex 
 GEN728R004 
 missense_variant 
 c.3847G>T 
 p.Ala1283Ser 
 Familial 
  
 Simplex 
 GEN728R005a 
 stop_gained 
 c.1648C>T 
 p.Arg550Ter 
 De novo 
  
  
 GEN728R005b 
 stop_gained 
 c.5725G>T 
 p.Glu1909Ter 
 De novo 
  
  
 GEN728R006 
 missense_variant 
 c.3785G>C 
 p.Arg1262Pro 
 De novo 
  
 Simplex 
 GEN728R007 
 stop_gained 
 c.2861G>A 
 p.Trp954Ter 
 De novo 
  
  
 GEN728R008 
 synonymous_variant 
 c.1422G>A 
 p.Pro474%3D 
 De novo 
  
 Simplex 
 GEN728R009 
 stop_gained 
 c.1471C>T 
 p.Gln491Ter 
 De novo 
  
  
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
4
Duplication
 1
 
4
Duplication
 1
 
4
Deletion-Duplication
 12
 

Model Summary

Variation in DHX genes, including DHX9, has been linked to neurodevelopmental disorders including autism spectrum disorder (ASD). The homozygous knockout model shows no change in viability but exhibits decreased body weight compared to sex-matched wildtypes. The model also shows altered behavioral and neurological function. Male and female model mice show decreased locomotion, with a decrease in distance traveled in the periphery of the open field and a decrease in locomotor speed. Additionally, model male and female mice demonstrate decreased grip strength, increased tremor, and decreased auditory functioning, as measured by the auditory brainstem response test. Furthermore, the model shows altered metabolic function, with possible altered renal function, decreased glucose clearance, and decreased cholesterol levels.

References

Type
Title
Author, Year
Model Type: Genetic
Model Genotype: Homozygous
Mutation: A targeting vector was designed to place an FRT- and loxP-flanked neomycin resistance cassette upstream of exon 3 and a loxP site downstream of exon 3. The construct was electroporated into BAC-BA1(129S/SvEV x C57BL/6)-derived embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts. Strong chimeras were identified and crossed to C57BL/6 females to verify germline transmission. The F1 generation was PCR screened and crossed to 129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J (JR#003946) to remove the FRT neo cassette.
Allele Type: Conditional knockout
Strain of Origin: (C57BL/6 x 129S/SvEv)F1
Genetic Background: C57BL/6N
ES Cell Line:
Mutant ES Cell Line:
Model Source: Jackson Laboratory
Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuronal activation: non-familiar social interaction1
Decreased
 Fiber photometry
 not specified
Neuronal activation: locomotion1
Increased
 Fiber photometry
 not specified
Social memory1
Decreased
 Three-chamber social approach test
 8-16 weeks
Social approach1
Decreased
 Three-chamber social approach test
 8-16 weeks
Differential gene expression: ASD risk genes1
Abnormal
 RNA sequencing
 not specified
Targeted expression1
Decreased
 Western blot
 not specified
DNA modification1
Decreased
 RNA sequencing
 not specified
DNA modification1
Decreased
 Dot blot
 not specified
Anxiety1
 No change
 Open field test
 8-16 weeks
Protein expression level evidence1
 No change
 Western blot
 not specified
General locomotor activity1
 No change
 Open field test
 8-16 weeks
Repetitive digging1
 No change
 Marble-burying test
 8-16 weeks
Self grooming1
 No change
 General observations
 8-16 weeks
 Not Reported:

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.